Filing Details

Accession Number:
0001209191-10-010170
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-17 12:00:00
Reporting Period:
2010-02-16
Filing Date:
2010-02-17
Accepted Time:
2010-02-17 20:07:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107332 Dendreon Corp DNDN Pharmaceutical Preparations (2834) 223203193
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1420482 W Mark Frohlich 3005 First Avenue
Seattle WA 98121
Svp,Ca & Mo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-02-16 382 $4.52 204,818 No 4 M Direct
Common Stock Disposition 2010-02-16 382 $32.00 204,436 No 4 S Direct
Common Stock Acquisiton 2010-02-16 938 $4.41 205,374 No 4 M Direct
Common Stock Disposition 2010-02-16 938 $32.00 204,436 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified stock option (right to buy) Acquisiton 2010-02-16 938 $32.00 938 $4.41
Common Stock Non-qualified stock option (right to buy) Acquisiton 2010-02-16 382 $32.00 382 $4.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,312 2016-12-06 No 4 M Direct
1,017 2016-03-16 No 4 M Direct
Footnotes
  1. These options vest as follows: 25% on the first anniversay and 1/36th monthly thereafter.